ACR适宜性标准®:常染色体显性多囊肾病
美国放射学会适宜性标准专家组基于证据分级方法,针对常染色体显性多囊肾病的初始诊断、总肾脏体积测定及并发症检测给出影像学检查适宜性建议。超声是初始诊断的首选,MRI是测定总肾脏体积的首选,增强CT是检测疑似并发症的首选。
要点
- 超声是常染色体显性多囊肾病初始诊断的首选检查,可检出小至2至3 mm的肾囊肿。
- MRI是测定总肾脏体积的首选模态,总肾脏体积可作为预测肾功能下降的影像生物标志物。
- 增强腹部和盆腔CT是检测疑似肾囊肿出血、破裂或感染等并发症的首选检查。
核心结论
- 超声因诊断准确度高且能检出小至2至3 mm的肾囊肿,是常染色体显性多囊肾病初始诊断的首选影像检查。
- MRI对检出小囊肿也高度敏感,可作为超声的替代检查;MRI是测定总肾脏体积的首选模态。
- 总肾脏体积可作为影像生物标志物预测肾功能下降、追踪疾病进展并评估治疗效果。
- 增强腹部和盆腔CT是检测疑似肾囊肿出血、破裂或感染等并发症的首选检查;增强腹部MRI也可用于诊断并发症,且通常适宜,不受肾功能影响。
研究设计与样本
- 美国放射学会适宜性标准:针对特定临床情况的循证指南,由多学科专家小组每年审查。
- 指南制定与修订过程支持对同行评议期刊医学文献的系统分析,采用GRADE等既定方法学原则评价证据。
- 采用RAND/UCLA适宜性方法用户手册确定特定临床场景下影像与治疗程序的适宜性。
- 同行评议文献缺乏或模棱两可时,专家可能是形成推荐意见的主要证据来源。
诊断标准与关键数值
- 超声诊断常染色体显性多囊肾病准确度高,可检出小至2至3 mm的肾囊肿。
- MRI对检出小囊肿也高度敏感,可作为超声的替代检查。
- MRI是测定总肾脏体积的首选模态;总肾脏体积可作为影像生物标志物预测肾功能下降、追踪疾病进展和评估治疗效果。
- 增强腹部和盆腔CT是检测疑似肾囊肿出血、破裂或感染等并发症的首选检查。
- 增强腹部MRI也可用于诊断常染色体显性多囊肾病并发症,且通常适宜,不受肾功能影响。
临床应用与阅片要点
- 初始诊断常染色体显性多囊肾病时首选超声,其可检出小至2至3 mm的囊肿。
- 需要测定总肾脏体积时首选MRI;总肾脏体积可用于预测肾功能下降、追踪疾病进展和评估疗效。
- 怀疑肾囊肿出血、破裂或感染等并发症时首选增强腹部和盆腔CT。
- 增强腹部MRI也可用于诊断并发症,且通常适宜,不受肾功能影响。
局限性
- 同行评议文献缺乏或模棱两可时,专家可能是形成推荐意见的主要证据来源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Ultrasound is the imaging study of choice for the initial diagnosis of autosomal dominant polycystic kidney disease (ADPKD) due to its high diagnostic accuracy and ability to detect kidney cysts as small as 2 to 3 mm. MRI of the kidneys is also highly sensitive at detecting small cysts and is an alternative to US. MRI is the preferred modality for determining total kidney volume (TKV). TKV can be used as an imaging biomarker to predict kidney function decline, track disease progression, and evaluate the effectiveness of treatment. CT abdomen and pelvis with contrast is the test of choice for detecting suspected complications such as renal cyst hemorrhage, rupture, or infection. MRI of the abdomen without and with contrast can also be used for diagnosing complications of ADPKD and is usually appropriate regardless of kidney function. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
引用
- Caserta MP, Purysko AS, Catanzano TM, et al. ACR Appropriateness Criteria® Autosomal Dominant Polycystic Kidney Disease. J Am Coll Radiol. 2026. PMID: 41823938. doi:10.1016/j.jacr.2026.02.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。